Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes.

C Jacob1, C Martin-Chouly, V Lagente

  • 1INSERM U456, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, Rennes, France.

Therapie
|August 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[When AIHA does not explain everything: parvovirus B19 infection and pancytopenia as a differential diagnostic challenge].

Innere Medizin (Heidelberg, Germany)·2025
Same author

The health economic burden of dengue in Germany: a retrospective analysis of statutory health insurance claims data.

Infectious diseases now·2025
Same author

Gelatin implant in the treatment of open-angle glaucoma: Safety and efficacy in real-life conditions.

Journal francais d'ophtalmologie·2022
Same author

Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data.

Orphanet journal of rare diseases·2019
Same author

Validity of a novel method to measure vertical oscillation during running using a depth camera.

Journal of biomechanics·2019
Same author

Claims Data Analysis on the Annual Frequency and Incremental Cost of Reoperations in Instrumental Spinal Surgeries in Germany.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Type 4 phosphodiesterases (PDE4) regulate inflammatory processes by controlling cyclic AMP (cAMP) levels. PDE4 inhibitors show potential for treating inflammatory diseases like asthma and COPD, but their therapeutic window needs improvement.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Type 4 phosphodiesterases (PDE4) are key enzymes regulating intracellular cyclic adenosine monophosphate (cAMP) levels.
  • PDE4 enzymes are predominantly expressed in inflammatory cells and play a crucial role in modulating inflammatory responses.
  • While cAMP-mediated pathways are known, recent findings suggest PDE4's involvement in inflammation extends beyond this.

Purpose of the Study:

  • To highlight PDE4 as a significant target for anti-inflammatory drug development.
  • To underscore the broad impact of PDE4 on various inflammatory mechanisms.
  • To acknowledge the therapeutic potential and limitations of current PDE4 inhibitors.

Main Methods:

  • Review of existing literature on PDE4 function and its role in inflammation.

Related Experiment Videos

  • Analysis of the biochemical pathways regulated by PDE4, including cAMP hydrolysis.
  • Examination of preclinical and clinical data regarding PDE4 inhibitors in inflammatory diseases.

    • Main Results:

    • PDE4 enzymes are critical regulators of inflammatory processes, including cellular trafficking, cytokine release, and reactive oxygen species production.
    • Elevation of cAMP by PDE4 inhibition can suppress multiple inflammatory pathways.
    • PDE4 inhibitors have demonstrated significant efficacy in preclinical models and clinical trials for conditions such as asthma and COPD.

    Conclusions:

    • PDE4 represents a promising therapeutic target for managing chronic inflammatory diseases.
    • Further research is needed to optimize PDE4 inhibitors for an improved therapeutic window and reduced side effects.
    • Understanding the full spectrum of PDE4's role in inflammation, including non-cAMP-dependent mechanisms, is essential for developing more effective treatments.